Medsider: Learn from MedTech and HealthTech Experts

How to Build a Strong Network of Investors and Partners for Your Medtech Startup: Interview with DermaSensor CEO Cody Simmons

August 22, 2022 Scott Nelson
Medsider: Learn from MedTech and HealthTech Experts
How to Build a Strong Network of Investors and Partners for Your Medtech Startup: Interview with DermaSensor CEO Cody Simmons
Show Notes

In this episode of Medsider Radio, we sat down with Cody Simmons, CEO of DermaSensor.

Cody spent four years learning about business strategy and analytics at biotechnology giant Genentech before becoming CEO of DermaSensor in 2016, where he leads development and commercialization efforts for the company’s novel skin cancer detection tool. In 2018, he was included on the Forbes 30 Under 30 list in healthcare.

In this discussion, Cody shares why he thinks companies need to focus on regulatory and reimbursement alignment from the very beginning, the importance of finding ally investors, and how to build trust with potential partners in your network.

Before we jump into the conversation, I wanted to mention a few things:

If you’re into learning from proven medtech and healthtech leaders, and want to know when new content and interviews go live, head over to Medsider.com and sign up for our free newsletter. You’ll get access to gated articles, and lots of other interesting healthcare content.

Second, if you want even more inside info from proven experts, think about a Medsider premium membership. We talk to experienced healthcare leaders about the nuts and bolts of running a business and bringing products to market.

This is your place for valuable knowledge on specific topics like seed funding, prototyping, insurance reimbursement, and positioning a medtech startup for an exit.

In addition to the entire back catalog of Medsider interviews over the past decade, premium members get a copy of every volume of Medsider Mentors sent to their door at no additional cost. If you’re interested, go to medsider.com/subscribe to learn more.

Lastly, here's the link to the full interview with Cody if you'd rather read it instead.